NEUROLOGY · 2026-2027 CYCLE
Away Intelligence →Away rotation benchmarks
Live acceptance rates and response times from the current cycle, powered by applicants tracking their aways on Rezumab. Combined with 64 historical records.
live this cycle
61
Applications
72%
Accept rate
25d
Median response
Program
This cycle
Accept
Median
How this works: "This cycle" reflects applicants tracking their aways on Rezumab right now. "Historical" is pulled from verified applicant reports (n=64). Accept rate and median response combine both sources. No identifying info is ever shown.
Add your aways. See the data get sharper.
Every applicant who tracks on Rezumab tightens these numbers for the next person. Takes under a minute to add your full list.